Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 1
1979 2
1980 1
1981 1
1982 2
1983 1
1985 3
1986 7
1987 2
1990 1
1991 4
1992 3
1993 5
1994 4
1995 2
1996 3
1997 2
1998 3
1999 4
2000 6
2003 3
2004 1
2005 3
2006 1
2008 5
2009 3
2010 2
2011 3
2012 3
2013 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

79 results
Results by year
Filters applied: . Clear all
Page 1
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Stupp R, et al. Among authors: janzer rc. N Engl J Med. 2005 Mar 10;352(10):987-96. doi: 10.1056/NEJMoa043330. N Engl J Med. 2005. PMID: 15758009 Free article. Clinical Trial.
MGMT gene silencing and benefit from temozolomide in glioblastoma.
Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R. Hegi ME, et al. Among authors: janzer rc. N Engl J Med. 2005 Mar 10;352(10):997-1003. doi: 10.1056/NEJMoa043331. N Engl J Med. 2005. PMID: 15758010 Free article.
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group. Stupp R, et al. Among authors: janzer rc. Lancet Oncol. 2009 May;10(5):459-66. doi: 10.1016/S1470-2045(09)70025-7. Epub 2009 Mar 9. Lancet Oncol. 2009. PMID: 19269895 Clinical Trial.
Morphological markers in neuro-oncology.
Kleihues P, Kiessling M, Janzer RC. Kleihues P, et al. Among authors: janzer rc. Curr Top Pathol. 1987;77:307-38. doi: 10.1007/978-3-642-71356-9_13. Curr Top Pathol. 1987. PMID: 2827963 Review. No abstract available.
Prognostic factors for low-grade gliomas.
Stupp R, Janzer RC, Hegi ME, Villemure JG, Mirimanoff RO. Stupp R, et al. Among authors: janzer rc. Semin Oncol. 2003 Dec;30(6 Suppl 19):23-8. doi: 10.1053/j.seminoncol.2003.11.029. Semin Oncol. 2003. PMID: 14765381 Review.
The blood-brain barrier: cellular basis.
Janzer RC. Janzer RC. J Inherit Metab Dis. 1993;16(4):639-47. doi: 10.1007/BF00711897. J Inherit Metab Dis. 1993. PMID: 8412011 Review.
The relation between solid cell nests and C cells of the thyroid gland: an immunohistochemical and morphometric investigation.
Janzer RC, Weber E, Hedinger C. Janzer RC, et al. Cell Tissue Res. 1979 Mar 19;197(2):295-312. doi: 10.1007/BF00233921. Cell Tissue Res. 1979. PMID: 373883 Review.
Expression of dual angiogenic/neurogenic growth factors in human primary brain tumors.
Clemessy M, Janzer RC, Lhermitte B, Gasc JM, Juillerat-Jeanneret L. Clemessy M, et al. Among authors: janzer rc. J Neurooncol. 2012 Mar;107(1):29-36. doi: 10.1007/s11060-011-0715-1. Epub 2011 Oct 7. J Neurooncol. 2012. PMID: 21979892
Heterogeneity of human glioblastoma: glutathione-S-transferase and methylguanine-methyltransferase.
Juillerat-Jeanneret L, Bernasconi CC, Bricod C, Gros S, Trepey S, Benhattar J, Janzer RC. Juillerat-Jeanneret L, et al. Among authors: janzer rc. Cancer Invest. 2008 Jul;26(6):597-609. doi: 10.1080/07357900802072913. Cancer Invest. 2008. PMID: 18584351
[Inflammatory and infectious manifestations of the nervous system].
Pizzolato GP, Janzer RC. Pizzolato GP, et al. Among authors: janzer rc. Rev Med Suisse Romande. 1999 Oct;119(10):799-804. Rev Med Suisse Romande. 1999. PMID: 10582492 Review. French.
79 results
Jump to page
Feedback